Background. The incidence of Kaposi sarcoma (KS) has reduced as a result of the introduction of antiretroviral therapy. It is currently considered a rare disease in developed countries, and there has been a paucity of clinical papers on the subject in recent years in Europe. Aim. To analyse the clinical features and evolution of the different clinical forms of KS in the past 30 years. Methods. Patients with cutaneous lesions of KS diagnosed during the period 1987-2016 at Bellvitge Hospital (an 800-bed university referral centre in Barcelona, Spain) were enrolled. Data recorded included age, sex, ethnicity, involved site, number of lesions, extracutaneous involvement, leg oedema, treatment, blood haemoglobin level, and blood cell (leucocyte, lymphocyte and CD4) counts. Results. Cutaneous lesions of KS were diagnosed in 191 patients (167 men, 24 women, mean AE SD age 51.95 AE 20.16 years). Clinical forms identified were classic KS (n = 53), acquired immunodeficiency syndrome (AIDS)-associated KS (n = 118), immunosuppression-associated KS (n = 18), and African endemic KS (n = 2). The number of patients diagnosed annually reached a maximum in the 1990s because of the AIDS epidemic, and has decreased since 2000. However, both classic KS and immunosuppression-associated KS doubled from the first to the second half of the analysed period. Cutaneous lesions involved the legs in 137 cases, and extracutaneous lesions were detected in 32 patients. In 46 of 118 patients with AIDS, the diagnosis of KS was simultaneous to the detection of human immunodeficiency virus infection. Conclusion. After a decrease in incidence since the middle of the 1990s, AIDSassociated KS continues to occur in Europe, and the number of annual cases of classic KS and immunosuppression-associated KS is increasing.
Introduction
Kaposi sarcoma (KS) is a solitary or multifocal lymphatic tumour, initially described almost 130 years ago in elderly men of Middle Eastern and Mediterranean descent. Cutaneous lesions usually present as violaceous macules that evolve into plaques and nodules. 1 Currently, four clinical forms of KS are recognized, all of which display indistinguishable histopathological features. Historically, KS occurred in two clinical subtypes: classic KS in elderly men of Mediterranean and Middle Eastern origin without apparent immunosuppression, and an African endemic form that occurs almost entirely in sub-Saharan Africa. A third type, KS associated with immunosuppressive states, develops mainly in solid organ transplant recipients but also in other immunosuppressed patients. Finally, in the 1980s, there appeared acquired immunodeficiency syndrome (AIDS)-associated KS, predominantly involving men who have sex with men (MSM). 1 This new epidemic form of KS led to a large increase in the worldwide incidence of KS in the 1990s; however, in the past two decades the incidence of AIDS-related KS has been reduced because of the use of highly active antiretroviral therapy (HAART). 2 KS is currently considered a rare disease in developed countries, and there is a paucity of recent clinical and epidemiological data in Europe. 3 Our objective was to analyse the clinical features and the evolution of the incidence of the different clinical forms of KS in the past 30 years in a university referral centre in Barcelona, Spain.
Methods
The study was approved by the institutional ethics committee of Hospital Universitari de Bellvitge. Informed consent was not required as this was a retrospective review of anonymous archival data.
Patients with cutaneous lesions of KS diagnosed between 1987 and 2016 at Bellvitge Hospital (an 800-bed university referral centre in Barcelona, Spain) were included in the study. The retrospective search was conducted by reviewing cases recorded as KS in our clinical database and cases coded as KS in the pathological database.
All patients were diagnosed histopathologically according to classic morphological criteria: irregularly shaped, slit-like vascular spaces lined by plump, relatively uniform spindled cells with well-defined cytoplasmic borders, extravasated erythrocytes, a variable lymphoplasmacytic infiltrate, haemosiderin-laden macrophages, and intracellular and extracellular eosinophilic hyaline globules. 4 Since 2012, immunohistochemical stain against human herpesvirus (HHV)-8 has been used to confirm the diagnosis.
The clinical charts of the patients were reviewed to obtain additional information, including patient age and sex, ethnicity, site of involvement, presence of mucosal or extracutaneous involvement, number of lesions, presence of leg oedema, and the administered treatment. Laboratory data recorded included blood haemoglobin level, leucocyte count and lymphocyte count. Finally, CD4 count was recorded for cases of AIDS-associated KS.
Statistical analysis
Data were entered into a database and analysed with SPSS software (v17.0; SPSS Inc. Chicago, IL, USA).
Categorical variables were compared using v² test or Fisher exact test. Continuous variables were compared using Student t-test or by analysis of variance when the normality of data distribution was confirmed.
Results
Cutaneous lesions of KS were diagnosed in 191 patients (167 men, 24 women; male : female ratio 7 : 1). Most patients were white from the western Mediterranean region (n = 174), while 9 were African, 2 northern European and 6 of South American descent. Mean AE SD age of the patients was 51.95 AE 20.16 years (range 20-96 years).
The clinical forms of KS identified were: classic (n = 53), AIDS-associated (n = 118), immunosuppression-associated (n = 18), and African endemic (n = 2). The number of patients diagnosed annually with the different forms of KS is shown in Fig. 1 Information about the initial lesion was obtained for 153 cases for macules (n = 17), plaques (n = 67) and nodules (n = 69). Information about the number of lesions at diagnosis was available for 157 cases (1 lesion in 40 cases, 2-10 in 62, and > 10 in 55). The cutaneous lesions involved the legs (n = 137), arms (n = 71), trunk (n = 64), head and neck (n = 51), genitals (n = 16), and oral mucosa (n = 41). The lesions were limited to the legs in 60 cases. In 89 cases, the lesions involved more than one anatomical region. Extracutaneous lesions were demonstrated in 32 patients (30 of whom had AIDS-associated KS, mostly manifesting as lymphadenopathy), while 34 patients had leg oedema (17.8%). In 46 of 118 patients with AIDS, the diagnosis of KS was simultaneous to the detection of HIV infection.
Concerning laboratory data, mean haemoglobin level was 121.68 AE 24.09 g/L, leucocyte count 6162.84 AE 7889.09 9 10 6 /L, and lymphocyte count 2293.70 AE 7627.95 9 10 6 /L. CD4 count (mean AE SD) for patients with AIDS-associated SK was 136.01 AE 153.25 9 10 6 /L, and this was not significantly different (P = 0.28) between the patients who had KS diagnosed at the same time as HIV (mean 155.75 9 10 6 /L) and those who had KD diagnosed later than HIV (117.32 9 10 6 /L).
Patients were followed up for a mean time period of 42.23 AE 52.68 months. Ten patients died of KS during the follow-up (all of them with AIDS-associated KS).
Discussion
The annual number of cases of KS diagnosed in our hospital reached a maximum in the 1990s because of the AIDS epidemic. As in other countries, the incidence of AIDS-associated KS decreased over time [from 87 cases in the first half of the analysed period (1987) (1988) (1989) (1990) (1991) (1992) (1993) (1994) (1995) (1996) (1997) (1998) (1999) (2000) (2001) to 31 in the second (2002) (2003) (2004) (2005) (2006) (2007) (2008) (2009) (2010) (2011) (2012) (2013) (2014) (2015) (2016) ]. However, the number of cases of classic KS and immunosuppression-associated KS doubled from the first to the second half of the period (classic KS increased from 18 to 35 cases and KS associated with immunosuppression increased from 6 to 12 cases). Overall, taking into account the initial reduction in the number of AIDS-associated KS since 2000, KS is currently increasing in our population. This may be attributable to the ageing of the Spanish population but also to an increase in the number of immunocompromised people. A spread of HHV-8 infection as a result of changes in sexual behaviour cannot be excluded. As the vast majority of KS cases are treated in reference hospitals such as ours, we believe these data are likely to be reflective of the general Spanish population. HHV-8 was identified in 1994 as the aetiological agent of KS, and is also associated with primary effusion lymphoma and multicentric Castleman disease. 5, 6 Like all herpesviruses, the HHV-8 lifecycle includes latent and lytic phases, and the virus persists for the life of the host. Therefore, seropositivity increases with age. 4 However, in contrast to other widely distributed herpesviruses, HHV-8 is not ubiquitous and has a heterogeneous global distribution. 6 HHV-8 seroprevalence rates are low in Northern Europe and the USA (0-5%), intermediate in Italy (5-35%) and Greece (13-20%), and highest in regions of sub-Saharan Africa and the Amazon (30-60%). 7 In Spain, the HHV-8 seroprevalence rate is 6.5% (8.0% in Catalonia). 8 The populations with the highest prevalence of HHV-8 infection in developed countries are HIVpositive MSM (86.7%) and HIV-negative MSM (28.0%). 8 Transmission of the virus is sexual in MSM, but asexual, probably via saliva, in areas of high endemicity. HHV-8 may also be transmitted by blood transfusions and by solid organ transplantation. 6 There are five major subtypes of HHV-8 (A, B, C, D and E), some of which predominate in different geographical areas of the world. 9 Although distinct genotypes may have different tumorigenic properties, only a minority of HHV-8-infected individuals develop KS, suggesting that additional adjuvant factors are required, the most important of which appears to be immunosuppression.
Classic KS is traditionally known as an indolent disease mostly involving the legs of elderly men, and progresses slowly over the course of many years. By contrast, AIDS-associated KS develops predominantly in MSM and can be rapidly progressive, often involving the head, neck, trunk and limbs. 1,2 Accordingly, in our study, classic KS and AIDS-associated KS showed important clinical differences. Age of diagnosis was 74.45 years in classic KS versus 39.04 years in AIDS-associated KS. Concerning sex, in AIDSassociated KS almost all patients were male, whereas in classic KS the male : female ratio was 2.5 : 1. In both clinical forms of KS, the most frequent location was the legs (classic KS 85%, AIDS-associated KS 63.56%). However, in classic KS the lesions were limited to the legs in 68% of patients versus only 9.31% in AIDS-associated KS. In fact, in AIDS-associated KS the lesions were more widespread, involving > 1 anatomical region in 61.86% of cases. The presence of oral involvement was highly indicative of AIDSassociated KS (38 of 41 patients with oral lesions had AIDS-associated KS). Leucopenia and anaemia were found predominantly in the epidemic form, obviously because of HIV infection ( Table 1) . Most of our patients with classic KS responded satisfactorily to therapy, and in some cases, the lesions stabilized even without any treatment. Only one patient with classic KS developed extracutaneous lesions. By contrast, extracutaneous lesions were detected in 28 of 118 patients with AIDS-associated KS, and the 10 patients who died due to KS had this clinical form. Immunosuppression-associated KS showed intermediate features between classic and AIDS-associated KS. These clinical differences between the different forms of KS can be explained by recent findings about the biology of HHV-8. Infection with HHV-8 induces endothelial cells to lose their typical cobblestone morphology and assume a spindle phenotype. It also skews blood endothelial cell differentiation towards lymphatic endothelial cells and vice versa.
9 Most HHV-8 genes are homologues of human genes involved in inflammation, cell cycle regulation and angiogenesis, such as viral cyclin-D1, vascular endothelial growth factor, fibroblast basic growth factor, interleukin (IL)-6 and IL-8.
9,10 HHV-8 also blocks some tumour suppressor proteins such as p53, and inhibits apoptosis. 4, 9, 10 The most important gene of latent HHV-8 is ORF73, which encodes LANA, an antigen used for preventing the presentation of histocompatibility antigens by infected cells, thus as a result, HHV-8 evades the immune response. 10 The predilection of AIDS-associated KS to affect men is usually attributed to the transmission of HHV-8 by anal intercourse in MSM. However, classic KS is also more frequent in men. A protective effect of female hormones against HHV-8 infection has been suggested as a possible explanation. In a study on immunodeficient mice, the beta-chain of human chorionic gonadotropin blocked tumorigenesis and metastasis of neoplastic KS cell lines. The similarity with the beta-chain of LH may explain the lower incidence of KS in women. 11, 12 The predilection for KS to involve the legs, especially in nonimmunocompromised patients, may be due to venous stasis producing local immunosuppression in the legs and therefore creating an immunologically vulnerable site for the development of KS. 4 In addition, it is known that venous stasis is capable of inducing vascular proliferations that are histopathologically similar to KS (pseudo-KS or acroangiodermatitis) that may favour replication of HHV-8 in these proliferating cells. It may be that severe immunosuppression and possible co-infection by HIV allow the virus to induce endothelial cell growth without requiring stimulating factors for endothelial cell proliferation related to stasis, thus explaining the more widespread lesions in these patients. Similarly, immunosuppression and HIV infection may explain the development of KS at a younger age in patients with AIDS.
Despite efforts towards early diagnosis of HIV infection and the free access to HAART in Spain, AIDSassociated KS cases are still occurring in our population. Although KS usually develops in advanced stages of HIV infection with CD4 lymphocyte count of < 200 9 10 6 /L (the mean CD4 count in our patients with AIDS-associated KS patients was 136 9 10 6 /L), in 46 of our 118 patients, AIDS-associated KS was diagnosed simultaneously with HIV infection. For this reason, recognition of the clinical features of KS remains useful for the diagnosis of HIV infection.
Conclusion
We observed a decrease in the incidence of AIDS-associated KS from the middle of the 1990s, as found in other studies. However, AIDS-associated KS cases continue to occur in our population, and the number of annual cases of classic KS and immunosuppressionassociated KS is increasing. We did not find any other study covering the incidence of KS in Mediterranean countries since 2002; it is possible that other countries with similar demographic characteristics might also have a similar incidence, and further studies are needed to confirm our data.
What's already known about this topic?
• The incidence of KS has reduced in the past two decades because of antiretroviral therapy, and is currently considered a rare disease in developed countries.
What does this study add?
• Classic KS and immunosuppression-associated KS are currently increasing in our European population.
• AIDS-associated KS continues to occur in Europe.
• Recognition of the clinical features of KS remains useful for the diagnosis of HIV infection.
